![Robert Redfield](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 166 322 $ am 31.05.2026
Robert Redfield is the founder of Prevention Diagnosis Treatment, Inc. President & Chief Executive Officer at R3 Enterprises & Consulting.
Director at Viriom, Inc. Senior Strategic Officer at Pasaca Capital, Inc. from 2021 to 2022.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Traws Pharma, Inc.
 Traws Pharma, Inc. BiotechnologyHealth Technology Discovers and develops products for patients with cancer 0,75 % | 08.03.2026 | 113.919 ( 0,75 % ) | 166 322 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Viriom, Inc.
 Viriom, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
Pasaca Capital, Inc.
 Pasaca Capital, Inc. Investment ManagersFinance Pasaca Capital invests in companies located in the United States. The firm focuses on a finance, government, IT and manufacturing sectors. It provides financing for growth capital requirements. | Corporate Officer/Principal | 01.01.2022 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
Viriom, Inc.
Viriom, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Pasaca Capital, Inc.
Pasaca Capital, Inc. Investment ManagersFinance Pasaca Capital invests in companies located in the United States. The firm focuses on a finance, government, IT and manufacturing sectors. It provides financing for growth capital requirements. | Finance |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
